603077 和邦生物
交易中 08-18 10:34:49
资讯
新帖
简况
图解和邦生物中报：第二季度单季净利润同比增长426.23%
证券之星 · 01:33
图解和邦生物中报：第二季度单季净利润同比增长426.23%
和邦生物最新公告：上半年净利润同比增长634.3%双甘膦、草甘膦、蛋氨酸市场价格上涨
证券之星 · 08-17 20:11
和邦生物最新公告：上半年净利润同比增长634.3%双甘膦、草甘膦、蛋氨酸市场价格上涨
和邦生物：公司目前暂未涉及磷化铟生产业务
证券之星 · 08-17 15:33
和邦生物：公司目前暂未涉及磷化铟生产业务
和邦生物：光伏玻璃1,900t/d、组件2GW、光伏硅片1.5—2GW
证券之星 · 08-14
和邦生物：光伏玻璃1,900t/d、组件2GW、光伏硅片1.5—2GW
和邦生物：公司2025年度以1.85亿元购买了2.5万吨/年黄磷产能指标
证券之星 · 08-14
和邦生物：公司2025年度以1.85亿元购买了2.5万吨/年黄磷产能指标
和邦生物(603077.SH)：未涉及磷化铟生产业务
中金财经 · 08-11
和邦生物(603077.SH)：未涉及磷化铟生产业务
和邦生物：公司目前未涉及磷化铟生产业务
证券之星 · 08-11
和邦生物：公司目前未涉及磷化铟生产业务
每周股票复盘：和邦生物（603077）减持8831.5万股，占比1.00%
证券之星 · 08-09
每周股票复盘：和邦生物（603077）减持8831.5万股，占比1.00%
和邦生物：公司各矿业权及在建项目情况，已在定期报告中真实、准确、完整地披露
证券之星 · 08-07
和邦生物：公司各矿业权及在建项目情况，已在定期报告中真实、准确、完整地披露
和邦生物：不涉及文旅、景区、酒店等经营领域
证券之星 · 08-07
和邦生物：不涉及文旅、景区、酒店等经营领域
和邦生物：减持计划期间为2026年3月2日至2026年9月1日
证券之星 · 08-07
和邦生物：减持计划期间为2026年3月2日至2026年9月1日
和邦生物：公司应用于饲料领域的产品主要为液体蛋氨酸
证券之星 · 08-07
和邦生物：公司应用于饲料领域的产品主要为液体蛋氨酸
和邦生物：持有四川省冕宁县缅萨洼金矿探矿权
证券之星 · 08-07
和邦生物：持有四川省冕宁县缅萨洼金矿探矿权
和邦生物：相关股份受让、公司回购股份处置产生的资金收益全部归入上市公司账户
证券之星 · 08-07
和邦生物：相关股份受让、公司回购股份处置产生的资金收益全部归入上市公司账户
和邦生物：严禁以任何形式干预二级市场股价
证券之星 · 08-07
和邦生物：严禁以任何形式干预二级市场股价
股市必读：和邦生物新发布《和邦生物关于集中竞价减持已回购股份的进展公告》
证券之星 · 08-05
股市必读：和邦生物新发布《和邦生物关于集中竞价减持已回购股份的进展公告》
和邦生物（603077）披露集中竞价减持已回购股份进展公告，8月3日股价上涨0.84%
证券之星 · 08-03
和邦生物（603077）披露集中竞价减持已回购股份进展公告，8月3日股价上涨0.84%
和邦生物：坚持夯实内在价值
证券之星 · 08-03
和邦生物：坚持夯实内在价值
和邦生物：公司现有草甘膦产能为6万吨/年
证券之星 · 08-03
和邦生物：公司现有草甘膦产能为6万吨/年
和邦生物：出售部分已回购股份支持主营业务和重点项目建设
证券之星 · 08-03
和邦生物：出售部分已回购股份支持主营业务和重点项目建设
加载更多
公司概况
公司名称：
四川和邦生物科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2012-07-31
主营业务：
四川和邦生物科技股份有限公司的主营业务是化工、农药、饲料添加剂、玻璃及制品、光伏材料及制品制造以及盐矿、磷矿的开发。公司的主要产品是磷矿、盐矿、联碱产品、双甘膦、草甘膦、二乙腈、蛋氨酸、智能玻璃、光伏玻璃及组件、硅片、农药产品，光伏工程建设、天然气管道运输及转供、成品油销售。
发行价格：
17.50
{"stockData":{"symbol":"603077","market":"SH","secType":"STK","nameCN":"和邦生物","latestPrice":2.43,"timestamp":1787020489000,"preClose":2.44,"halted":0,"volume":93098109,"delay":0,"changeRate":-0.0041,"floatShares":8832000000,"shares":8832000000,"eps":-0.0425,"marketStatus":"交易中","change":-0.01,"latestTime":"08-18 10:34:49","open":2.43,"high":2.47,"low":2.41,"amount":227000000,"amplitude":0.0246,"askPrice":2.43,"askSize":5610,"bidPrice":2.42,"bidSize":44622,"shortable":0,"etf":0,"ttmEps":-0.0425,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1787023800000},"marketStatusCode":2,"adr":0,"adjPreClose":2.44,"symbolType":"stock","openAndCloseTimeList":[[1787016600000,1787023800000],[1787029200000,1787036400000]],"highLimit":2.68,"lowLimit":2.2,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":8831705728,"isCdr":false,"pbRate":1.21,"roa":"--","roe":"2.08%","epsLYR":-0.0672,"committee":-0.060798,"marketValue":21461000000,"turnoverRate":0.0105,"status":1,"floatMarketCap":21461000000},"requestUrl":"/m/hq/s/603077","defaultTab":"news","newsList":[{"id":"2660315524","title":"图解和邦生物中报：第二季度单季净利润同比增长426.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660315524","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660315524?lang=zh_cn&edition=full","pubTime":"2026-08-18 01:33","pubTimestamp":1786988022,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物2026年中报显示，上半年度公司主营收入28.88亿元，同比下降26.34%；归母净利润3.8亿元，同比上升634.3%；扣非净利润3.75亿元，同比上升698.33%；其中2026年第二季度，公司单季度主营收入15.0亿元，同比下降31.66%；单季度归母净利润2.07亿元，同比上升426.23%；单季度扣非净利润2.04亿元，同比上升429.26%；负债率34.74%，投资收益684.8万元，财务费用6355.82万元，毛利率28.87%。财报数据概要请见下图:本文数据来源于和邦生物2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800001683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487578","title":"和邦生物最新公告：上半年净利润同比增长634.3%双甘膦、草甘膦、蛋氨酸市场价格上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660487578?lang=zh_cn&edition=full","pubTime":"2026-08-17 20:11","pubTimestamp":1786968681,"startTime":"0","endTime":"0","summary":"和邦生物(603077.SH)公告称，公司发布2026年半年度报告，实现营业收入28.88亿元，同比下降26.34%；归属于上市公司股东的净利润3.8亿元，同比增长634.3%。业绩增长主要系报告期内公司主要产品双甘膦、草甘膦、蛋氨酸市场价格上涨，带动公司整体利润增长。注：公司Q2净利润2.07亿，Q1净利润1.74亿，据此计算，Q2净利润环比增长18%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700030758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660048850","title":"和邦生物：公司目前暂未涉及磷化铟生产业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2660048850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660048850?lang=zh_cn&edition=full","pubTime":"2026-08-17 15:33","pubTimestamp":1786952026,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物(603077)08月17日在投资者关系平台上答复投资者关心的问题。投资者提问：智联招聘看到贵公司招聘磷化铟合成研发工程师，是不是准备进行磷化铟的相关研发工作？研发有成后，是否有相关的后续规划？和邦生物回复：尊敬的投资者您好，公司目前暂未涉及磷化铟生产业务。公司为聚焦新赛道和新产品，于近期成立了新材料研究所，目前仍处于前期调研、论证阶段，关于公司的业务布局与发展规划，请以公司在指定信披网站及媒体披露的公告为准。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700014218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0027","BK0132","BK0229","BK0196","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659110725","title":"和邦生物：光伏玻璃1,900t/d、组件2GW、光伏硅片1.5—2GW","url":"https://stock-news.laohu8.com/highlight/detail?id=2659110725","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659110725?lang=zh_cn&edition=full","pubTime":"2026-08-14 18:00","pubTimestamp":1786701657,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物(603077)08月14日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在光伏板块主要产品为光伏玻璃、组件、硅片及EPC工程业务，那么公司各产品已经落地在运行的产能分别是多少？工厂在哪里？和邦生物回复：尊敬的投资者您好，根据公司《2025年年度报告》，公司光伏玻璃及其他板块的主要产品及产能为：光伏玻璃1,900t/d、组件2GW、光伏硅片1.5—2GW，以及光伏EPC工程业务等，相关主体为公司控股子公司四川武骏光能及其下属企业。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400032529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0027","603077","BK0132","BK0077","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659110764","title":"和邦生物：公司2025年度以1.85亿元购买了2.5万吨/年黄磷产能指标","url":"https://stock-news.laohu8.com/highlight/detail?id=2659110764","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659110764?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:57","pubTimestamp":1786701444,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物(603077)08月14日在投资者关系平台上答复投资者关心的问题。投资者提问：和邦生物是不是黄磷细分概念股？和邦生物回复：尊敬的投资者您好，市场层面的题材概念股并无官方统一定义。根据《2025年年度报告》，公司2025年度以1.85亿元购买了2.5万吨/年黄磷产能指标，拟于乐山市犍为县布局建设黄磷生产项目。以上信息供您参考，感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400032192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0229","BK0196","BK0077","BK0027","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658998747","title":"和邦生物(603077.SH)：未涉及磷化铟生产业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2658998747","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658998747?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:07","pubTimestamp":1786435622,"startTime":"0","endTime":"0","summary":"格隆汇8月11日丨和邦生物(603077.SH)在投资者互动平台表示，公司目前未涉及磷化铟生产业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260811/32331540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0229","BK0077","BK0132","603077","BK0027","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658960725","title":"和邦生物：公司目前未涉及磷化铟生产业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2658960725","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658960725?lang=zh_cn&edition=full","pubTime":"2026-08-11 15:34","pubTimestamp":1786433664,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物(603077)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问：智联招聘看到招聘磷化铟合成研发工程师，准备进军磷化铟产业？和邦生物回复：尊敬的投资者您好，公司目前未涉及磷化铟生产业务。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100019566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0196","BK0027","BK0132","BK0229","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658673762","title":"每周股票复盘：和邦生物（603077）减持8831.5万股，占比1.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658673762","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658673762?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:03","pubTimestamp":1786212194,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，和邦生物报收于2.41元，较上周的2.37元上涨1.69%。本周，和邦生物8月5日盘中最高价报2.46元。公司于2026年1月30日披露减持计划，拟在2026年3月2日至9月1日期间减持不超过176,630,744股，占总股本比例不超过2%。截至2026年7月31日，已通过集中竞价交易方式减持88,315,000股，占总股本的1.00%，成交均价为3.01元/股，减持总金额为265,785,700.04元。减持后当前持股数量为430,203,309股，持股比例为4.87%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0077","BK0196","BK0229","603077","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614750","title":"和邦生物：公司各矿业权及在建项目情况，已在定期报告中真实、准确、完整地披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614750","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657614750?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:57","pubTimestamp":1786096641,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物08月07日在投资者关系平台上答复投资者关心的问题。为严格遵守信息披露公平性、审慎性原则，避免误导市场，公司不便对矿产资源价值进行主观测算，亦无法将项目资源与公司市值进行简单对标。公司将坚持聚焦主业经营，努力提升经营质量与内在价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700032355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0229","603077","BK0027","BK0196","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657195614","title":"和邦生物：不涉及文旅、景区、酒店等经营领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2657195614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657195614?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:55","pubTimestamp":1786096524,"startTime":"0","endTime":"0","summary":"请问公司是否考虑借鉴峨眉山A等上市公司经验，推出持股股东专属乐山旅游福利，联合本地景区、酒店为股东提供门票减免、住宿优惠等权益？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700031949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0077","603077","BK0196","BK0229","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614168","title":"和邦生物：减持计划期间为2026年3月2日至2026年9月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614168","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657614168?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:55","pubTimestamp":1786096521,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物08月07日在投资者关系平台上答复投资者关心的问题。和邦生物回复：尊敬的投资者您好，根据公司前期披露的《关于集中竞价减持公司已回购股份计划的公告》，公司计划减持前期已回购股份的期间为2026年3月2日至2026年9月1日。后续减持将根据市场情况在计划期间内择机实施，并严格遵守相关规则关于交易时间窗口的规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700031933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0132","BK0196","BK0077","BK0027","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657121614","title":"和邦生物：公司应用于饲料领域的产品主要为液体蛋氨酸","url":"https://stock-news.laohu8.com/highlight/detail?id=2657121614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657121614?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:55","pubTimestamp":1786096520,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物(603077)08月07日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在饲料产业链有哪些产品及布局，产品产能或规划产能是多少？和邦生物回复：尊敬的投资者您好，公司应用于饲料领域的产品主要为液体蛋氨酸。相关产品的具体产能规模及项目规划，请参阅公司定期报告或相关公告。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700031927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0196","603077","BK0132","BK0027","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657161415","title":"和邦生物：持有四川省冕宁县缅萨洼金矿探矿权","url":"https://stock-news.laohu8.com/highlight/detail?id=2657161415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657161415?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:55","pubTimestamp":1786096517,"startTime":"0","endTime":"0","summary":"和邦生物回复：尊敬的投资者您好，公司金矿项目情况已在《2025年年度报告》中详细披露，主要包括：国内方面，公司持有四川省冕宁县缅萨洼金矿探矿权，权益比例100%，目前初勘工作实施中，2026年工作计划为完成初勘工作并开展进一步详勘。海外方面，公司通过投资澳大利亚AEV公司持有Jundee金矿探矿权，矿区位于澳大利亚西澳大利亚州，当前进展为详勘计划初步确定、待实施，2026年工作计划为启动详勘。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700031922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603077","BK0229","BK0132","BK0077","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657149506","title":"和邦生物：相关股份受让、公司回购股份处置产生的资金收益全部归入上市公司账户","url":"https://stock-news.laohu8.com/highlight/detail?id=2657149506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657149506?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:54","pubTimestamp":1786096462,"startTime":"0","endTime":"0","summary":"公司回购股份用于员工持股计划时，始终严格按照不低于回购成本进行定价转让；历次员工持股计划的资金来源为公司员工的合法薪酬或通过法律、行政法规允许的其他方式取得的资金，相关股份受让、公司回购股份处置产生的资金收益全部归入上市公司账户，专项用于补充公司日常经营及重点项目建设流动资金，不存在收益流失、被个人或第三方占用的情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700031841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0196","BK0077","BK0229","BK0132","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614146","title":"和邦生物：严禁以任何形式干预二级市场股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657614146?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:54","pubTimestamp":1786096459,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物08月07日在投资者关系平台上答复投资者关心的问题。各上市公司经营策略、发展阶段、业务结构及市场估值逻辑存在显著差异，公司无法评价其他上市公司的经营行为与市场表现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700031830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0077","BK0027","BK0196","603077","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657655335","title":"股市必读：和邦生物新发布《和邦生物关于集中竞价减持已回购股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657655335","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657655335?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:36","pubTimestamp":1785868572,"startTime":"0","endTime":"0","summary":"公司公告汇总：截至2026年7月31日，和邦生物已减持回购股份88,315,000股，占总股本1.00%，成交均价3.01元/股，减持总金额265,785,700.04元。公司公告汇总和邦生物关于集中竞价减持已回购股份的进展公告四川和邦生物科技股份有限公司于2024年4月至8月期间通过集中竞价交易方式回购股份合计227,027,340股，占公司总股本的2.57%。公司于2026年1月30日披露减持计划，拟在2026年3月2日至9月1日期间减持不超过176,630,744股，占总股本比例不超过2%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0196","603077","BK0027","BK0077","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656377626","title":"和邦生物（603077）披露集中竞价减持已回购股份进展公告，8月3日股价上涨0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656377626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656377626?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:24","pubTimestamp":1785767060,"startTime":"0","endTime":"0","summary":"近日，和邦生物发布《关于集中竞价减持已回购股份的进展公告》。公告显示，公司于2024年4月至8月期间通过集中竞价交易方式回购股份合计227,027,340股，占公司总股本的2.57%。公司于2026年1月30日披露减持计划，拟在2026年3月2日至9月1日期间减持不超过176,630,744股，占总股本比例不超过2%。截至2026年7月31日，已通过集中竞价交易方式减持88,315,000股，占总股本的1.00%，成交均价为3.01元/股，减持总金额为265,785,700.04元。减持后当前持股数量为430,203,309股，持股比例为4.87%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0196","603077","BK0027","BK0077","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656326020","title":"和邦生物：坚持夯实内在价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2656326020","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656326020?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:33","pubTimestamp":1785742396,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物(603077)08月03日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，贵公司如何维护公司市值，为什么股价这么暴跌都不响应号召回购股票？维护股东权益，难道一点实质行动都没？和邦生物回复：尊敬的投资者您好，我们十分理解您对公司股价表现的关切。二级市场股价受多重因素影响，存在不确定性。公司高度重视市值管理，始终将深耕主业、提升经营质量为核心工作，坚持夯实内在价值。市值管理相关举措请参考公司已披露的“提质增效重回报”行动方案。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300014429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0132","BK0027","603077","BK0196","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656329895","title":"和邦生物：公司现有草甘膦产能为6万吨/年","url":"https://stock-news.laohu8.com/highlight/detail?id=2656329895","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656329895?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:33","pubTimestamp":1785742395,"startTime":"0","endTime":"0","summary":"证券之星消息，和邦生物(603077)08月03日在投资者关系平台上答复投资者关心的问题。投资者提问：公司现在的草甘膦产能是5万吨还是6万吨/年？现在每年产量有多少？印尼草甘膦项目产能是多少？什么时间能投产？印尼草甘膦项目投产后公司的草甘膦总产能是多少？是否能超越拜耳产能和兴发集团产能？和邦生物回复：尊敬的投资者您好，公司现有草甘膦产能为6万吨/年，印尼草甘膦项目设计产能为35万吨/年，计划于2027年四季度投料生产。关于具体产量及与其他企业的产能对比，请以各公司公开披露信息为准。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300014427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0027","BK0196","603077","BK0229","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656298923","title":"和邦生物：出售部分已回购股份支持主营业务和重点项目建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2656298923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656298923?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:33","pubTimestamp":1785742391,"startTime":"0","endTime":"0","summary":"和邦生物是不是一切为了套现，绝无可能把回购专户里的股份进行注销？请您关注公司在上海证券交易所发布的公告。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300014419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0196","603077","BK0027","BK0077","BK0229"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787020492983,"stockEarnings":[{"period":"1week","weight":-0.0161},{"period":"1month","weight":0.0844},{"period":"3month","weight":-0.0929},{"period":"6month","weight":0.0252},{"period":"1year","weight":0.3048},{"period":"ytd","weight":0.0796}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.058},{"period":"3month","weight":-0.0448},{"period":"6month","weight":-0.0244},{"period":"1year","weight":0.0773},{"period":"ytd","weight":0.0035}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川和邦生物科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"236236人(较上一季度减少14.16%)","perCapita":"37385股","listingDate":"2012-07-31","address":"四川省乐山市五通桥区牛华镇沔坝村","registeredCapital":"883170万元","survey":" 四川和邦生物科技股份有限公司的主营业务是化工、农药、饲料添加剂、玻璃及制品、光伏材料及制品制造以及盐矿、磷矿的开发。公司的主要产品是磷矿、盐矿、联碱产品、双甘膦、草甘膦、二乙腈、蛋氨酸、智能玻璃、光伏玻璃及组件、硅片、农药产品，光伏工程建设、天然气管道运输及转供、成品油销售。","listedPrice":17.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和邦生物(603077)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和邦生物(603077)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和邦生物,603077,和邦生物股票,和邦生物股票老虎,和邦生物股票老虎国际,和邦生物行情,和邦生物股票行情,和邦生物股价,和邦生物股市,和邦生物股票价格,和邦生物股票交易,和邦生物股票购买,和邦生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和邦生物(603077)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和邦生物(603077)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}